Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world (it affects 30% of the general adult population). The NAFLD encompasses a histological spectrum ranging from simple steatosis to nonalcoholic steatohepatitis (NASH), defined by steatosis, hepatocel...
Saved in:
| Main Authors: | Marilena Durazzo, Paola Belci, Alessandro Collo, Enrica Grisoglio, Simona Bo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | International Journal of Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2012/464706 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nonalcoholic Fatty Liver Disease
by: Branka Filipović, et al.
Published: (2018-01-01) -
Mechanisms and therapeutic implications of selective autophagy in nonalcoholic fatty liver disease
by: Suwei Jin, et al.
Published: (2025-01-01) -
Biomarkers in Nonalcoholic Fatty Liver Disease
by: Manuela G Neuman, et al.
Published: (2014-01-01) -
Nonmedicinal Interventions in Nonalcoholic Fatty Liver Disease
by: Manuela G Neuman, et al.
Published: (2015-01-01) -
Noninvasive assessment of nonalcoholic fatty liver disease
by: Gajanan A Rodge, et al.
Published: (2021-01-01)